Seed Round - Interius BioTherapeutics
Investment Firm
Overview
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.
Announced Date
Mar 13, 2020
Funding Type
Seed
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Interius BioTherapeutics raised $5500000 on 2020-03-13 in Seed Round
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 13, 2020 |  Seed Round - Interius BioTherapeutics | 5 | - | 5.5M |
| May 18, 2021 | Series A - Interius BioTherapeutics | 16 | - | 76.0M |
| Oct 20, 2023 | Debt Financing - Interius BioTherapeutics | - | 21.5M | |
| Jun 03, 2024 | Series B - Interius BioTherapeutics | - | 51.4M |
Recent Activity
There is no recent news or activity for this profile.